1. Home
  2. RCKT

RCKT

Rocket Pharmaceuticals Inc.

Logo Rocket Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Founded: N/A Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 2.3B IPO Year: N/A
Target Price: $51.70 AVG Volume (30 days): 724.2K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.92 EPS Growth: N/A
52 Week Low/High: $14.89 - $32.53 Next Earning Date: 05-02-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 751.80%

Share on Social Networks: